T-type Ca channel blockade as a determinant of kidney protection.
about
Hypoxia: The Force that Drives Chronic Kidney DiseaseScreening Ingredients from Herbs against Pregnane X Receptor in the Study of Inductive Herb-Drug Interactions: Combining Pharmacophore and Docking-Based Rank Aggregation.T-type calcium channel blocker attenuates unilateral ureteral obstruction-induced renal interstitial fibrosis by activating the Nrf2 antioxidant pathway.Off the beaten renin-angiotensin-aldosterone system pathway: new perspectives on antiproteinuric therapy.NKCC1 and hypertension: role in the regulation of vascular smooth muscle contractions and myogenic tone.Role of dihydropyridinic calcium channel blockers in the management of hypertension.1,4-dihydropyridines: the multiple personalities of a blockbuster drug family.Renal microcirculation and calcium channel subtypesRoles of lymphocyte kv1.3-channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels.Factors associated with the reduction of albumin excretion in diabetic hypertensive patients: differential effect of manidipine versus amlodipine.Comparative Effect of Calcium Channel Blockers on Glomerular Function in Hypertensive Patients with Diabetes Mellitus.Voltage-activated Ca(2+) channels in rat renal afferent and efferent myocytes: no evidence for the T-type Ca(2+) current.Effects of a benidipine-based combination therapy on the risk of stroke according to stroke subtype: the COPE trial.Effect of Angiotensin-Converting Enzyme Inhibitor/Calcium Antagonist Combination Therapy on Renal Function in Hypertensive Patients With Chronic Kidney Disease: Chikushi Anti-Hypertension Trial - Benidipine and Perindopril.Lercanidipine valuable effect on urine protein losses: the RED LEVEL study.Lercanidipine in the Management of Hypertension: An Update.Effects of azelnidipine and amlodipine on exercise-induced sympathoexcitation assessed by pupillometry in hypertensive patients.Consensus Recommendations for Standard Therapy of Glomerular Disease in Dogs
P2860
Q26768865-FCD53C9D-EEF3-4935-B30F-25389E01BECEQ35960314-3C5CB986-1DF0-42BA-9176-CFBFC927D250Q37448061-245B73F5-05B4-4BD2-9B0F-4ADFBC767314Q37904098-24AFD6BD-3C8C-4F55-9E90-074B70E0C84AQ38019992-A9A2CC87-6F83-4B48-B149-8F3FBA74487EQ38069195-DEE9D8E4-25EE-4E59-BA5E-1157B374427DQ38125687-A9D40C01-997B-46AA-9DD9-F682834ABD81Q38183458-556037DD-5180-490C-B3FF-8B14C8E6A16FQ38417868-9E8A2496-40E1-4B1B-82A9-08BC933EDAD2Q38790925-891A3779-FD47-447E-AD67-9AFFA8CDD843Q40173093-CE9B5DBC-A148-4461-AA31-9988B2D2054DQ46212510-E916FF48-405F-4B63-BC99-2E919E636C7DQ46877368-DC2D3BE2-E0A0-4EE9-8C3D-865F872E17B8Q47215335-9ABA9427-1906-476C-9420-46029994BE48Q50225845-48F0C967-A689-408C-901D-B3463E9AE978Q52689065-79DE8955-CD27-417F-ACAF-F906B3F6AF42Q54791214-7F6F18F1-34CC-4362-A38B-A46D46BB4B45Q57425110-BBBA7414-7865-4EB4-B4B0-60944C688E82
P2860
T-type Ca channel blockade as a determinant of kidney protection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T-type Ca channel blockade as a determinant of kidney protection.
@en
T-type Ca channel blockade as a determinant of kidney protection.
@nl
type
label
T-type Ca channel blockade as a determinant of kidney protection.
@en
T-type Ca channel blockade as a determinant of kidney protection.
@nl
prefLabel
T-type Ca channel blockade as a determinant of kidney protection.
@en
T-type Ca channel blockade as a determinant of kidney protection.
@nl
P2093
P356
P1476
T-type Ca channel blockade as a determinant of kidney protection.
@en
P2093
Hirobumi Tokuyama
Hiroshi Itoh
Koichi Hayashi
Koichiro Homma
Naoki Sugano
Shu Wakino
Takao Saruta
P356
10.2302/KJM.59.84
P577
2010-01-01T00:00:00Z